Streamlined approach to testing for heparin-induced thrombocytopenia improves diagnostic accuracy

A new study appearing in The Journal of Applied Laboratory Medicine (JALM) has found that a simplified version of the standard screening method for identifying heparin-induced thrombocytopenia (HIT)—a dangerous side effect of the blood thinner heparin—did a better job than the full technique of identifying which patients had the condition.